Sala, Monera .

HRN: 24-43-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2024
CEFUROXIME 750MG (VIAL)
07/12/2024
07/13/2024
IV
1.5g
Q8
Pelvic Lap
Rejected 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Non-compliant To Guidelines